Latest Board Recommendations News

MAC Copper Limited has entered a binding agreement for acquisition by Harmony Gold, offering shareholders a compelling 32% premium and signalling a major consolidation in the copper mining sector.

New World Resources Limited has entered a binding agreement for acquisition by Central Asia Metals Plc at a significant premium, valuing the company at approximately A$185 million. The transaction, unanimously recommended by New World’s board, is set to complete by September 2025, subject to shareholder and court approvals.

Xanadu Mines has received a takeover bid from Bastion at A$0.08 per share, representing a substantial premium and backed unanimously by the board and major shareholder CAAF. The offer includes a $17.2 million capital injection and is subject to limited conditions.

NSX Limited has entered a Scheme Implementation Deed with CNSX Markets Inc. for a full acquisition at a 59% premium, subject to shareholder and regulatory approvals. The deal aims to strengthen NSX’s market position and expand its product offerings.

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.

Envirosuite Limited has entered a binding Scheme Implementation Deed with UK-based Ideagen Limited, agreeing to a full acquisition at a significant premium. The transaction values Envirosuite at approximately A$132.2 million and awaits shareholder and regulatory approvals.

Engenco Limited’s independent board committee recommends shareholders accept Elph Investments’ 30.5 cents per share takeover offer, despite an independent expert deeming the price ‘not fair but reasonable’. The offer, conditional on increasing Elph’s stake to over 92%, presents shareholders with a choice between immediate liquidity and longer-term exposure.

PointsBet Holdings Limited has announced a scheme meeting for shareholders to vote on its proposed $1.06 per share acquisition by MIXI Australia, with an independent expert deeming the offer fair and reasonable amid a competing bid from betr Entertainment.

Argenica Therapeutics has completed patient dosing in its Phase 2 trial of ARG-007 for acute ischaemic stroke, with topline data expected in Q3 2025. The company also plans to submit its Investigational New Drug application and Fast Track request to the FDA imminently.

Hotel Property Investments (HPI) reported a robust half-year profit of A$16.7 million, driven by rising rental income and property valuations, while managing significant takeover defence costs amid Charter Hall Retail REIT and Hostplus bids.

Brookfield Capital Partners has submitted a non-binding proposal to acquire Insignia Financial at A$4.60 per share, matching rival offers and setting the stage for a competitive bidding process.

AUCyber Limited confirms control has passed to 5GN following a substantial holding disclosure, with the Board unanimously recommending shareholders accept 5GN's last and final offer closing on 17 February 2025.